+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Male Infertility Market by Test, Treatment Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904835
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Male Infertility Market grew from USD 3.77 billion in 2023 to USD 4.09 billion in 2024. It is expected to continue growing at a CAGR of 8.94%, reaching USD 6.88 billion by 2030.

Male infertility refers to a man's inability to cause pregnancy in a fertile female partner. It is a multifaceted issue influenced by various genetic, physiological, lifestyle, and environmental factors. The necessity for addressing male infertility is underscored by its prevalence, affecting an estimated 7% of men worldwide and contributing to approximately 50% of infertility cases in couples. In application, medical interventions such as hormone treatment, surgery, and assisted reproductive technologies (ART) like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are prevalent. End-use sectors include healthcare facilities, fertility clinics, and research institutions investing in advanced diagnostic solutions and treatments.

Key growth factors in the male infertility market include advancements in medical technology, rising awareness about reproductive health, and social shifts towards delayed parenthood. The increasing incidence of lifestyle diseases like obesity and diabetes, known to impact fertility, also drives market demand. Opportunities include developing non-invasive diagnostic tools and personalized treatment plans, which could increase market penetration. Startups and established companies can tap into artificial intelligence and machine learning to enhance the accuracy and efficacy of diagnostic procedures and treatments. Collaborations with research institutions can further accelerate innovation.

However, market growth is challenged by the high cost of treatment, social stigma, and limited awareness in developing regions. Regulatory barriers and the complexity of diagnosing male infertility add another layer of difficulty. Companies must prioritize affordability and access, employ strategic marketing to destigmatize male infertility, and invest in educational campaigns to raise global awareness. Innovative efforts should focus on genetic research, including gene editing and epigenetics, to understand better and treat underlying causes. The male infertility market is dynamic, characterized by rapid technological advancement. For businesses keen on growth, leveraging partnerships and emerging technologies, while overcoming barriers to access and affordability, will be key in navigating this evolving landscape.

Understanding Market Dynamics in the Male Infertility Market

The Male Infertility Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing awareness and education about male infertility
    • Increased prevalence of male infertility cases due to lifestyle-related factors
    • Expanding healthcare infrastructure with enhanced accessibility to male infertility diagnostic and treatment services
  • Market Restraints
    • High costs associated with male infertility treatments
  • Market Opportunities
    • Growing trend of personalized medicine with tailored treatment plans
    • Technological advancements in gene-editing
  • Market Challenges
    • Limited insurance coverage for male infertility treatments

Exploring Porter’s Five Forces for the Male Infertility Market

Porter’s Five Forces framework further strengthens the insights of the Male Infertility Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Male Infertility Market

External macro-environmental factors deeply influence the performance of the Male Infertility Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Male Infertility Market

The Male Infertility Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Male Infertility Market

The Male Infertility Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Male Infertility Market

The Male Infertility Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Male Infertility Market, highlighting leading vendors and their innovative profiles. These include Aarti Medicals Pvt. Ltd., Adorefem, Andrology Solutions, Bayer AG, CinnaGen Co., Cipla Limited, Dallas IVF, Ferring Global, Gladfem by Zoic Group, Glenmark Pharmaceuticals Limited, HCA International Limited, Intas Pharmaceuticals Ltd., Male Fertility & Sexual Medicine Specialists, Maze Laboratories, Merck KGaA, Midwest Fertility Specialists, NTMIC Sperm Lab, Oasis Fertility, SCSA Diagnostics, Inc., Shady Grove Fertility, Sun Pharmaceutical Industries Limited, Theramex, Vitrolife Sweden AB, Winfertility, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Male Infertility Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Test
    • Computer-Assisted Semen Analysis
    • DNA Fragmentation Technique
    • Microscopic Examination
    • Oxidative Stress Analysis
    • Sperm Agglutination
    • Sperm Penetration Assay
  • Treatment Type
    • Assisted Reproductive Technologies & Surgery
    • Medication
  • End User
    • Fertility Centers
    • Hospitals & Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Male Infertility Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of infertility in male due to lifestyle and environmental issues
5.1.1.2. Rising adoption of assisted reproductive technologies
5.1.1.3. Introduction of technology-driven male infertility treatments options
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Rising medical tourism
5.1.3.2. Growing awareness and changing lifestyle with rising R&D expenditure
5.1.4. Challenges
5.1.4.1. Social stigma
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Male Infertility Market, by Test
6.1. Introduction
6.2. Computer-Assisted Semen Analysis
6.3. DNA Fragmentation Technique
6.4. Microscopic Examination
6.5. Oxidative Stress Analysis
6.6. Sperm Agglutination
6.7. Sperm Penetration Assay
7. Male Infertility Market, by Treatment
7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
8. Americas Male Infertility Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Male Infertility Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Male Infertility Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Andrology Solutions
12.1.2. Bayer AG
12.1.3. Cadila Pharmaceuticals by Zydus Lifesciences Limited
12.1.4. CinnaGen Co.
12.1.5. EMD Sereno, Inc. by Merck KGaA
12.1.6. Endo International PLC
12.1.7. Halotech DNA S.L.
12.1.8. Intas Pharmaceuticals Ltd.
12.1.9. Sanofi SA
12.1.10. SCSA Diagnostics, Inc.
12.1.11. Theramex
12.1.12. Vitrolife Sweden AB
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MALE INFERTILITY MARKET RESEARCH PROCESS
FIGURE 2. MALE INFERTILITY MARKET SIZE, 2022 VS 2030
FIGURE 3. MALE INFERTILITY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MALE INFERTILITY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MALE INFERTILITY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MALE INFERTILITY MARKET DYNAMICS
FIGURE 7. MALE INFERTILITY MARKET SIZE, BY TEST, 2022 VS 2030 (%)
FIGURE 8. MALE INFERTILITY MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 10. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MALE INFERTILITY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MALE INFERTILITY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 6. MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 13. MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MALE INFERTILITY MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. CANADA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 23. CANADA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. MEXICO MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 25. MEXICO MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. CHINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 35. CHINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. INDIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 37. INDIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. JAPAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 41. JAPAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. THAILAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 53. THAILAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 60. DENMARK MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. EGYPT MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 62. EGYPT MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. FINLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 64. FINLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. FRANCE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 66. FRANCE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GERMANY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 68. GERMANY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. ITALY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 72. ITALY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. NORWAY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 78. NORWAY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. POLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 80. POLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. QATAR MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 82. QATAR MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SPAIN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 90. SPAIN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. TURKEY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 96. TURKEY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 102. MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 103. MALE INFERTILITY MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Male Infertility market, which are profiled in this report, include:
  • Aarti Medicals Pvt. Ltd.
  • Adorefem
  • Andrology Solutions
  • Bayer AG
  • CinnaGen Co.
  • Cipla Limited
  • Dallas IVF
  • Ferring Global
  • Gladfem by Zoic Group
  • Glenmark Pharmaceuticals Limited
  • HCA International Limited
  • Intas Pharmaceuticals Ltd.
  • Male Fertility & Sexual Medicine Specialists
  • Maze Laboratories
  • Merck KGaA
  • Midwest Fertility Specialists
  • NTMIC Sperm Lab
  • Oasis Fertility
  • SCSA Diagnostics, Inc.
  • Shady Grove Fertility
  • Sun Pharmaceutical Industries Limited
  • Theramex
  • Vitrolife Sweden AB
  • Winfertility
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information